OCEA — Ocean Biomedical, Inc.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1869974 ·
Last close
$0.00
Market Cap
$46.5K
52W High
$0.01
52W Low
$0.00
ADV30
42,270
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2025 | 0 | — | -958,000 | -8,240,000 | 1,582,000 | 0 | 93,981,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-356,000
Investing CF
—
Financing CF
$909,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.09
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-213,775,000
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-7,897,000
Pretax Income TTM
$-8,240,000
Interest Exp TTM
$343,000
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2024 | 0 | -3,798,000 | -9,480,000 | 902,000 | 98,518,000 | -97,616,000 | -4,180,000 |
| Dec 2023 | 0 | -10,214,000 | -114,466,000 | 5,501,000 | 96,264,000 | -90,763,000 | -9,429,000 |
| Dec 2022 | 0 | -16,121,000 | -17,359,000 | 1,842,000 | 12,661,000 | -10,819,000 | -993,000 |
| Dec 2021 | 0 | -62,345,000 | -62,344,000 | 108,652,342 | 3,396,444 | 105,255,898 | -1,053,000 |
TTM Snapshot
Revenues TTM
$0
NetIncome TTM
$-30,719,000
OpCashFlow TTM
—
Assets (Latest)
$1,582,000
Forward EPS
$-0.89
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| XTXXF | Adastra Holdings Ltd. | $39.2K | $0.01 | — |
| RGBPP | Regen BioPharma Inc | $79.4K | $0.00 | — |
| PRPH | ProPhase Labs, Inc. | $90.4K | $0.01 | — |
| PTPI | Petros Pharmaceuticals, Inc. | $139.8K | $0.00 | — |
| BDPT | BIOADAPTIVES, INC. | $15.0K | $0.00 | — |
Recent Insider Activity
No insider activity indexed for this ticker.